Despite a year of trade tensions, national security strictures and stark warnings about the U.S.’ waning biotech innovation edge, the…

In a groundbreaking study set to reshape our understanding of Parkinson’s disease (PD), researchers have unveiled critical epigenetic modifications in…

In a groundbreaking clinical investigation set against the delicate backdrop of neonatal care, a new study spearheaded by researchers Comley,…

Recent research highlights a significant breakthrough in the realm of pediatric medicine, specifically addressing the pressing issue of metabolic-associated fatty…

In an era where educational systems are actively seeking to transcend traditional methodologies, recent research indicates that adopting a growth…

Six people, including a former employee of investment bank Citigroup’s San Francisco office, have been charged in an $41 million…

For the third year in a row, Fierce Biotech’s Layoff Tracker is topping the tree as the story with the…

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease…

In recent years, the ability of artificial intelligence to generate human-like text has rapidly transformed various fields, including education and…